TenNor Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series E
Recent Raise
$42.1M
TenNor Therapeutics develops novel therapies for bacterial infections and metabolic diseases, with a focus on treatments for _Helicobacter pylori_ and prosthetic joint infections.
Focus Areas
Bacterial infections
Metabolic diseases
Clinical-stage
Drug development
FDA designations
Helicobacter pylori
Investors
